United States · FDA National Drug Code directory
Levetiracetam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-181_2de4ebba-b125-4355-35f5-69b92e56634b
- Product NDC
- 55111-181
- Form
- TABLET
- Composition / generic term
- Levetiracetam
- Labeler
- Dr. Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090115
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVETIRACETAM — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (55111-181-01) · 55111-181-01
- 120 TABLET in 1 BOTTLE (55111-181-04) · 55111-181-04
- 500 TABLET in 1 BOTTLE (55111-181-05) · 55111-181-05
- 30 TABLET in 1 BOTTLE (55111-181-30) · 55111-181-30
- 1 BLISTER PACK in 1 CARTON (55111-181-79) / 10 TABLET in 1 BLISTER PACK · 55111-181-79
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →